Healthcare >> CEO Interviews >> June 8, 2023

Interview with the President and CEO: Clearpoint Neuro Inc. (NASDAQ:CLPT)

Burnett, Joseph M.
Joseph M. Burnett joined Clearpoint Neuro Inc. as Chief Executive Officer and President and became a member of the board of directors in November 2017. Prior to joining ClearPoint Neuro, he served as Vice President and General Manager of Neuro Diagnostics and Therapy at Royal Philips, a publicly traded global health technology company, since March 2016. Prior to serving in this role, Mr. Burnett was the Senior Vice President and Business Leader of Image Guided Therapy Devices at Royal Philips and General Manager of Volcano Corporation (a Royal Philips company) from February 2015 to March 2016. Before joining Royal Philips, Mr. Burnett worked for Volcano Corporation, where he served in various positions from November 2004 to February 2015, most recently as Executive Vice President and General Manager of its Coronary & Systems Business Unit. Prior to joining Volcano Corporation, Mr. Burnett served as an R&D Engineer and Product Manager at Guidant Corporation from August 1999 to November 2004 and worked as a Bio-Medical Engineering Researcher at Duke University from May 1998 to May 1999. Mr. Burnett holds an MBA from The Fuqua School of Business at Duke University and a B.S.E. degree in BioMedical Engineering from Duke University. Profile
Word count: 3,548

TWST: Can you give us an overview of the company, how it got started, its mission and how it’s evolved over the years?

Mr. Burnett: So,